Search

Your search keyword '"Bruckert, Eric"' showing total 1,176 results

Search Constraints

Start Over You searched for: Author "Bruckert, Eric" Remove constraint Author: "Bruckert, Eric"
1,176 results on '"Bruckert, Eric"'

Search Results

1. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).

4. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

5. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

6. Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia

7. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

9. More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke

10. Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy

11. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia

12. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

13. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

14. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia

15. Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions

16. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

17. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

18. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk

19. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

20. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia:A multi-national study

23. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia

25. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

27. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

29. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

30. Age- and Sex-Based Heterogeneity in Coronary Artery Plaque Presence and Burden in Familial Hypercholesterolemia: A Multi-National Study

31. Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey

34. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

35. Efficacy of evinacumab by low-density lipoprotein receptor genotype and function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study

37. Regulation of HDL dysfunctionality by phosphatidylethanolamine links poly-unsaturated fatty acids with atherosclerotic cardiovascular diseases

38. A new method for classifying severe hypercholesterolaemia

40. Cardiovascular contrasted phenotypes in patients with familial hypercholesterolemia: Design and baseline characteristics of the SAFIR study.

50. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Catalog

Books, media, physical & digital resources